Prchal, Josef T.
Josef Prchal americký lékař-hematolog českého původu
Prchal, Josef T., 19..-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 160949845 (Personal)
Permalink: http://viaf.org/viaf/160949845
Preferred Forms
-
100 0 _
‡a
Josef Prchal
‡c
americký lékař-hematolog českého původu
-
100 1 _ ‡a Prchal, Josef T.
-
100 1 _ ‡a Prchal, Josef T.
-
100 1 _ ‡a Prchal, Josef T.
-
100 1 _ ‡a Prchal, Josef T.
-
100 1 _ ‡a Prchal, Josef T.
-
100 1 _
‡a
Prchal, Josef T.
-
100 1 _
‡a
Prchal, Josef T.
-
100 1 _
‡a
Prchal, Josef T.
-
100 1 _
‡a
Prchal, Josef T.,
‡d
19..-....
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Acute kernicterus in a neonate with O/B blood group incompatibility and a mutation in SLC4A1. |
|
| Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease |
|
| Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia |
|
| Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent clone from coexisting CLL |
|
| Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression |
|
| Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias |
|
| Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells |
|
| Delivery on demand--a new era of gene therapy? |
|
| Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera |
|
| Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells |
|
| Does HUMARA assay for assessment of clonal hematopoiesis have shortcomings? |
|
| Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia |
|
| Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis |
|
| Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo |
|
| Essential role for Nix in autophagic maturation of erythroid cells |
|
| The evolution of cellular deficiency in GATA2 mutation |
|
| Evolutionary history of Tibetans inferred from whole-genome sequencing. |
|
| Experimental Modeling of Myeloproliferative Neoplasms |
|
| Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera |
|
| Genetic adaptation to extreme hypoxia: study of high-altitude pulmonary edema in a three-generation Han Chinese family |
|
| Hematopoiesis is not clonal in healthy elderly women. |
|
| The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia |
|
| Hypoxia and thrombosis |
|
| Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease |
|
| Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload |
|
| Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001 |
|
| In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs |
|
| In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele |
|
| Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden. |
|
| Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha |
|
| Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts |
|
| Ironing out the role of hepcidin in infection. |
|
| The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation |
|
| JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia |
|
| Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers |
|
| Metabolic insight into mechanisms of high-altitude adaptation in Tibetans |
|
| Methylation of AR locus does not always reflect X chromosome inactivation state |
|
| miR-451 enhances erythroid differentiation in K562 cells |
|
| Missense mutation of the last nucleotide of exon 1 (G->C) of beta globin gene not only leads to undetectable mutant peptide and transcript but also interferes with the expression of wild allele |
|
| Molecular basis of two novel mutations found in type I methemoglobinemia. |
|
| MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis |
|
| Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. |
|
| Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects |
|
| Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome |
|
| Novel α-spectrin mutation in trans with α-spectrin causing severe neonatal jaundice from hereditary spherocytosis. |
|
| Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis |
|
| Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea |
|
| Plasma quantitation of JAK2 mutation is not suitable as a clinical test: an artifact of storage |
|
| Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study. |
|
| Red cell and its diseases |
|
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals |
|
| Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis |
|
| Retracted: EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors |
|
| Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia |
|
| Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera |
|
| Variations in both α-spectrin (SPTA1) and β-spectrin ( SPTB ) in a neonate with prolonged jaundice in a family where nine individuals had hereditary elliptocytosis. |
|
| Vascular complications in Chuvash polycythemia |
|
| Williams hematology |
|
| X-linked clonality testing: interpretation and limitations |
|
